Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2602 of 5804
-
Blood test could unlock new treatments for mysterious cancer
Knowledge-focused Recruiting nowCancer of Unknown Primary (CUP) is where cancer cells are found in the body but the place the cancer began is not known. It is the 6th leading cause of cancer death in the UK and the prognosis is poor with a median survival of 6-9 months. There is a higher than average incidence …
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Leg heat therapy shows promise for heart failure patients
Symptom relief Recruiting nowThe objective of this pilot study is to establish evidence to support the validity of HT in improving skeletal muscle function and physical capacity of patients with HFpEF. Our central hypothesis is that HT treatment will lead to improvements in skeletal muscle and microvascular …
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Cherry juice tested as shield against chemo nerve pain
Prevention Recruiting nowThis is a single institution phase II randomized study evaluating the potential benefits of a supplement, tart cherry juice at high- versus low-doses, to prevent taxane induced peripheral neuropathy in breast and ovarian cancer patients undergoing paclitaxel chemotherapy. Eligib…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New hope for dialysis patients who can't use standard blood thinners
Disease control Recruiting nowA prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at h…
Phase: NA • Sponsor: Talphera, Inc • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New pill takes on tough cancers in first human test
Disease control Recruiting nowThis is a first-in-human, multicenter, open-label, phase 1 study to evaluate safety, tolerability, and efficacy of CID-078, a Cyclin A/B-RxL inhibitor, in patients with advanced solid tumors.
Phase: PHASE1 • Sponsor: Circle Pharma • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC
-
Can a culturally adapted yoga program help black adults move more and boost wellbeing?
Symptom relief OngoingThis community-based study will assess the efficacy of a culturally adapted, yoga-based intervention to reduce sitting time, increase physical activity, and improve psychosocial wellbeing among insufficiently active Black adults in the Houston area.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a Split-Second glance at a scary face cure social anxiety?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to identify the circuit activations by very brief exposure (VBE) among youth with social anxiety disorder (SAD) in order to develop a novel intervention for those with SAD. The secondary objectives of this study are to measure the effect of VBE …
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Yoga vs. insomnia: new study tests if stretching beats sleeplessness
Symptom relief Recruiting nowThis study will evaluate the effect of the yoga in participants with chronic insomnia. The primary objective is to determine whether adding yoga to standard care improves insomnia severity, as measured by the Insomnia Severity Index (ISI), compared to standard care alone. The stu…
Phase: NA • Sponsor: All India Institute of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Silkworm pupa tablets tested to fight frailty after cancer surgery
Symptom relief CompletedThis is a randomized, double-blind, very low dose parallel-controlled, prospective, multi-center trial evaluating the improvement of nutritional status and frailty with silkworm pupa tablets after radical resection of gastrointestinal malignancies for 3 months intervention. The p…
Phase: NA • Sponsor: Xiaosun Liu, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New pill could stop hives from scratching or cold
Disease control CompletedThis phase 2a trial will evaluate the safety and efficacy of EVO756 in subjects with chronic inducible urticaria, including symptomatic dermographism and cold urticaria.
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New MRI technique could sharpen radiation for deadly brain tumors
Knowledge-focused Recruiting nowThis study is designed to evaluate the role of Oxygen Enhanced (OE) Magnetic resonance imaging (MRI) and Blood Oxygenation Level Dependent (BOLD) MRI in detecting regions of hypoxic tumour and to evaluate their use as imaging methods to selectively deliver targeted radiotherapy t…
Sponsor: University of Sydney • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Water bottles in schools may fight tooth decay and weight gain
Prevention Recruiting nowThe goal of this study is to determine the effectiveness and sustainability of a community-participatory hydration intervention over 3 years within a district that has newly installed hydration stations and is operating under a policy designed to enhance heathy hydration practice…
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC
-
New drug combo targets tough cancers in early trial
Disease control Recruiting nowThis Phase 1, multi-center, open-label, dose escalation and dose optimization study is designed to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PDx), and preliminary clinical activity of MOMA-313 administered orally as a single agent or combination th…
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New dialysis approach aims to boost muscle strength in kidney patients
Disease control Recruiting nowThe concept of renal rehabilitation has become increasingly important with the increasing age of patients with severe or even terminal chronic kidney disease (CKD). It combines physical exercise and nutritional monitoring programs for patients with terminal CKD who are most often…
Phase: NA • Sponsor: Brugmann University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Phone app could boost lung recovery after surgery
Symptom relief CompletedThe goal of this pilot clinical trial is to assess the feasibility of smartphone-based telerehabilitation for inspiratory muscle training (IMT) and to explore its preliminary effects on postoperative recovery in high-risk adult patients after lung resection. Eligible participants…
Phase: NA • Sponsor: Pusan National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Weight fluctuations may worsen PCOS symptoms, new study investigates
Disease control Recruiting nowThis study prospectively includes PCOS patients with normal weight and overweight/obesity, closely follows up and intensively manages them, and observes the level and distribution of weight reduction achieved by patients after lifestyle intervention (high-protein diet for weight …
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can coaching replace pills? new trial targets pain and depression in black patients
Symptom relief Recruiting nowThis project is part of the NIH Helping to End Addiction Long-term (HEAL) initiative (https://heal.nih.gov/). This randomized controlled trial (RCT) is phase 2 of a two-phase, 5-year project with the overarching goal of testing a decision aid (DA)/coaching intervention, tailored …
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Shining a light on leg pain: new trial tests simple home therapy for PAD
Symptom relief Recruiting nowThe ENLIGHTEN PAD Trial will collect preliminary data to test whether daily 660 nm light treatment of the lower extremities immediately before home-based walking exercise sessions improves six-minute walk distance at 4-month follow-up, compared to sham light, in people with lower…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New scan could help track rare Cancer's response to treatment
Diagnosis CompletedThis phase II trial tests whether gallium-68 (Ga-68) prostate specific membrane antigen (PSMA)-11 positron emission tomography (PET)/computed tomography (CT) imaging is useful for detecting therapy response in patients with adenoid cystic carcinoma (salivary gland cancer) that ha…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 26, 2026 15:54 UTC
-
New group therapy aims to ease anxiety and depression in autistic teens
Symptom relief Recruiting nowThe goal of this open clinical trial is to try out and evaluate a group metacognitive treatment protocol, for adolescents aged 15-18 years of age with anxiety and/or depression and an autism diagnosis. The main questions it aims to answer are: 1. How does the recruitment to the…
Phase: NA • Sponsor: Uppsala University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC